Novavax Overview

  • Founded
  • 1987
Founded
  • Status
  • Public
  • Employees
  • 691
Employees
  • Stock Symbol
  • NVAX
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $230.29
  • (As of Tuesday Closing)

Novavax General Information

Description

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.

Contact Information

Website
www.novavax.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 21 Firstfield Road
  • Gaithersburg, MD 20878
  • United States
+1 (240) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novavax Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$230.29 $226.92 $76.59 - $331.68 $16.9B 74.5M 4.87M -$13.73

Novavax Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 14,193,487 7,235,150 378,127 896,166
Revenue 1,181,929 475,598 18,662 34,288
EBITDA (915,780) (398,229) (114,830) (164,401)
Net Income (949,910) (418,259) (132,694) (184,748)
Total Assets 2,749,587 1,582,479 172,957 207,978
Total Debt 430,322 471,762 321,873 319,187
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Novavax Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novavax‘s full profile, request access.

Request a free trial

Novavax Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development wi
Biotechnology
Gaithersburg, MD
691 As of 2020
00000
000000000 00000

0000000

nim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
000000000000000
Vancouver, WA
00 As of 0000
00000
000000000 00000

0000000

ore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000 000000000
Tübingen, Germany
000 As of 0000
00.000
00000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novavax Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cytodyn Formerly Angel backed Vancouver, WA 00 00000 000000000 00000
0000000 Formerly VC-backed Tübingen, Germany 000 00.000 00000000 00.000
00000000000 Formerly VC-backed Louisville, CO 0 00000 000000&0 00000
000000 Formerly VC-backed Ghent, Belgium 000 00000 000000&0 00000
000000 Venture Capital-Backed San Diego, CA 0 00.000 0000000000 0 00.000
You’re viewing 5 of 34 competitors. Get the full list »

Novavax Executive Team (28)

Name Title Board Seat Contact Info
Stanley Erck Chief Executive Officer & Board Member
Gregory Glenn President, Research and Development
Gregory Covino Executive Advisor
James Kelly Chief Financial Officer, Finance & Executive Vice President
Richard Crowley Chief Operating Officer & Executive Vice President
You’re viewing 5 of 28 executive team members. Get the full list »

Novavax Board Members (12)

Name Representing Role Since
00000 0000 Self Board Member 000 0000
00000 00000 00 Self Board Member 000 0000
00000 00000 00.0 Self Chairman & Board Member 000 0000
00000000 0000000 Novavax Board Member 000 0000
0000000 0000000 00. Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Novavax Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novavax Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novavax‘s full profile, request access.

Request a free trial

Novavax Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00 27-May-2020 000000000000000000 00000 Pharmaceuticals 0000000 0000
Novavax (Maryland) 22-Aug-2013 Merger/Acquisition 0000 Drug Discovery 0000 00000000 000
To view Novavax’s complete acquisitions history, request access »

Novavax Subsidiaries (1)

Company Name Industry Location Founded
0000000 00 Pharmaceuticals Jevany, Czech Republic
To view Novavax’s complete subsidiaries history, request access »